Definium Therapeutics (DFTX) had the highest return between January 1, 2020 and March 30, 2020 by a mid-cap US stock, returning 687.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | 1/1/2020 - 3/30/2020 | 687.5% |
Aura Minerals Inc Common Shares (AUGO) | 1/1/2020 - 3/30/2020 | 107.12% |
Schrodinger (SDGR) | 1/1/2020 - 3/30/2020 | 62.23% |
Acm Research (ACMR) | 1/1/2020 - 3/30/2020 | 60.12% |
Virtu Financial (VIRT) | 1/1/2020 - 3/30/2020 | 35.93% |
Ringcentral (RNG) | 1/1/2020 - 3/30/2020 | 34.14% |
Arcus Biosciences (RCUS) | 1/1/2020 - 3/30/2020 | 31.88% |
Youdao (DAO) | 1/1/2020 - 3/30/2020 | 30.89% |
Chewy (CHWY) | 1/1/2020 - 3/30/2020 | 29.6% |
Arcutis Biotherapeutics (ARQT) | 1/1/2020 - 3/30/2020 | 28.79% |
Zai Lab (ZLAB) | 1/1/2020 - 3/30/2020 | 26.87% |
iRhythm Technologies (IRTC) | 1/1/2020 - 3/30/2020 | 25.9% |
Enphase Energy (ENPH) | 1/1/2020 - 3/30/2020 | 21.35% |
Cytokinetics (CYTK) | 1/1/2020 - 3/30/2020 | 20.21% |
Bilibili (BILI) | 1/1/2020 - 3/30/2020 | 17.93% |
Palomar (PLMR) | 1/1/2020 - 3/30/2020 | 17.11% |
Five9 (FIVN) | 1/1/2020 - 3/30/2020 | 15.4% |
Enliven Therapeutics (ELVN) | 1/1/2020 - 3/30/2020 | 14.29% |
Liquidia Technologies (LQDA) | 1/1/2020 - 3/30/2020 | 12.3% |
Denali Therapeutics (DNLI) | 1/1/2020 - 3/30/2020 | 12.19% |
GDS (GDS) | 1/1/2020 - 3/30/2020 | 10.69% |
Tootsie Roll Industries (TR) | 1/1/2020 - 3/30/2020 | 10.11% |
Kiniksa Pharmaceuticals (KNSA) | 1/1/2020 - 3/30/2020 | 9.99% |
Indivior PLC Ordinary Shares (INDV) | 1/1/2020 - 3/30/2020 | 9.57% |
Freshpet (FRPT) | 1/1/2020 - 3/30/2020 | 7.81% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.